MedPath

The Impact of Local Analgesia for Postoperative Analgesia in Posterior Thoracolumbar Operation

Phase 4
Completed
Conditions
Pain
Interventions
Registration Number
NCT01872494
Lead Sponsor
Guangzhou General Hospital of Guangzhou Military Command
Brief Summary

Posterior thoracolumbar operation always chooses general anesthesia. Due to surgical trauma and rich periosteum and joint capsule innervation, patients after general anesthesia immediately feel acute pain.The use of appropriate postoperative analgesia in patients with thoracolumbar surgery is beneficial to postoperative recovery. Infusions of local anaesthetic via multilumen catheters that deliver directly to wound sites have been used for postoperative analgesia in procedures. Reducing the morbidity from both pain and nausea will make the mode of analgesia a better tolerated and more palatable option for patients. The aim of this study is to examine the effects of using local anaesthetic infusion catheters following posterior thoracolumbar surgery, and compares the outcomes of patients managed using intravenous analgesia pump infusion of systemic opioids.

Detailed Description

All 71 adult patients were prospectively included and randomized to either the local (L) group (n=35) or the intravenous (V) group (n=36) by using a random number table: the test group were treated with local analgesia infusion pump of 0.33% ropivacaine through the wound for postoperative analgesia, while the control group were treated with intravenous analgesia pump infusion of flurbiprofen axetil,palonosetron, pentazocine. At 2, 4, 6, 12, 24, 36, 48 hours after operation, postoperative pain visual analogue scale(VAS) scores and sedation Ramsay scores were used to evaluate the level of pain and sedation, and investigators documented the comprehensive evaluation of patients with pain control system, and the incidence of adverse reactions. At 24, 48 hours investigators observed the wound whether inflammation and exudation or not, and the removal of penetration catheter sent to clinical laboratory for bacterial culture. Investigators also recorded the length of time to discharge and called to ask pain conditions at the first 3 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
71
Inclusion Criteria
  1. ASA Ⅰ ~ Ⅱ patient undergoing elective posterior thoracolumbar operation
  2. between 18 and 70 years of age
Exclusion Criteria
  1. A history of cardiopulmonary disease, liver and kidney dysfunction, abnormal coagulation
  2. Preoperative use of analgesic drugs
  3. A allergy history of ropivacaine and polyurethane material

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
intravenousflurbiprofen axetil 150mg,palonosetron 0.5mg,pentazocine 240mg.This group is treated with intravenous analgesia pump infusion of flurbiprofen axetil 150mg,palonosetron 0.5mg,pentazocine 240mg.
intravenousintravenousThis group is treated with intravenous analgesia pump infusion of flurbiprofen axetil 150mg,palonosetron 0.5mg,pentazocine 240mg.
LocallocalThis group uses local analgesia infusion pump of 0.33% ropivacaine 250ml through the wound for postoperative analgesia.
Local0.33% ropivacaine 250mlThis group uses local analgesia infusion pump of 0.33% ropivacaine 250ml through the wound for postoperative analgesia.
Primary Outcome Measures
NameTimeMethod
pain48 hours postoperation

Up to 48 hours after operation,postoperative pain visual analogue scale(VAS) scores are used to evaluate the level of pain.

Secondary Outcome Measures
NameTimeMethod
sedation48 hours postoperation

At 2, 4, 6, 12, 24, 36, 48 hours after operation,sedation Ramsay scores are used to evaluate the level of sedation.

comprehensive evaluation48 hours postoperation

Investigators document the comprehensive evaluation of patients with pain control system,including the incidence of adverse reactions.

Trial Locations

Locations (1)

Guangzhou Military Region General Hospital, Department of Anesthesiology

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath